These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3271317)

  • 21. Relationship between intercellular adhesion molecule-1 and HLA class II expression in acute cellular rejection of human kidney allografts.
    von Willebrand E; Loginov R; Salmela K; Isoniemi H; Häyry P
    Transplant Proc; 1993 Feb; 25(1 Pt 2):870-1. PubMed ID: 8095111
    [No Abstract]   [Full Text] [Related]  

  • 22. A positive B cell crossmatch due to IgG anti-HLA-DQ antibody present at the time of transplantation in a successful renal allograft.
    Taylor CJ; Chapman JR; Fuggle SV; Ting A; Morris PJ
    Tissue Antigens; 1987 Sep; 30(3):104-12. PubMed ID: 3321555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonradioactive DNA/RFLP analysis for HLA DR and DQ allotypes.
    Crosby I; Beales P; Barnes RM
    Transplant Proc; 1992 Dec; 24(6):2481-2. PubMed ID: 1361259
    [No Abstract]   [Full Text] [Related]  

  • 24. Modulation of the immune response with major histocompatability class II peptides via the indirect pathway of allorecognition after kidney and small bowel transplantation.
    Gasser M; Lenhard SM; Otto C; Kist-van Holthe JE; Navarro E; Timmermann W; Ulrichs K; Thiede A; Waaga AM
    Transplant Proc; 2002 Sep; 34(6):2244-5. PubMed ID: 12270384
    [No Abstract]   [Full Text] [Related]  

  • 25. DQ molecules are the principal stimulators of de novo donor-specific antibodies in nonsensitized pediatric recipients receiving a first kidney transplant.
    Tagliamacco A; Cioni M; Comoli P; Ramondetta M; Brambilla C; Trivelli A; Magnasco A; Biticchi R; Fontana I; Dulbecco P; Palombo D; Klersy C; Ghiggeri GM; Ginevri F; Cardillo M; Nocera A
    Transpl Int; 2014 Jul; 27(7):667-73. PubMed ID: 24629017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular analysis of graft survival in renal transplantation by DNA typing of HLA class II antigens.
    Tsuji K; Inoko H; Ando A; Matsuno N; Ikewaki N; Sato T; Ichikawa Y; Sonoda T
    Transplant Proc; 1987 Feb; 19(1 Pt 1):662-3. PubMed ID: 3152706
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of pretransplant antibodies on early renal allograft rejection.
    Alarif L; Rodriguez R; Blackburn S; Light JA
    Transplant Proc; 1987 Feb; 19(1 Pt 1):771-2. PubMed ID: 3274869
    [No Abstract]   [Full Text] [Related]  

  • 28. Abrogation of anti-HLA antibodies via proteasome inhibition.
    Trivedi HL; Terasaki PI; Feroz A; Everly MJ; Vanikar AV; Shankar V; Trivedi VB; Kaneku H; Idica AK; Modi PR; Khemchandani SI; Dave SD
    Transplantation; 2009 May; 87(10):1555-61. PubMed ID: 19461494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T cells specific for viral antigens presented by HLA-Dw4 recognize DR13 on allogeneic cells: a possible mechanism for induction of rejection.
    Gjertsen HA; Lundin KE; Hansen T; Thorsby E
    Transplant Proc; 1993 Feb; 25(1 Pt 1):70-1. PubMed ID: 8382384
    [No Abstract]   [Full Text] [Related]  

  • 30. Specific "intra-allele" and "intra-broad antigen" human leukocyte antigen alloantibodies in kidney graft transplantation.
    Muro M; González-Soriano MJ; Salgado G; López R; Boix F; López M; Campillo JA; Martínez P; Botella C; Gimeno L; Minguela A; Alvarez-López MR; Llorente S
    Hum Immunol; 2010 Sep; 71(9):857-60. PubMed ID: 20510320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
    Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
    Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA typing on peripheral blood lymphocytes from cadaveric donors to reduce cold ischemia.
    Muñoz C; Franco A; Prados MC; de la Sen ML; Perdiguero M; Olivares J
    Transplant Proc; 1992 Dec; 24(6):2490-1. PubMed ID: 1465840
    [No Abstract]   [Full Text] [Related]  

  • 33. Class II antigen and interleukin-2 expression in renal allograft recipients.
    Nowaczyk M; Lao M; Maldyk M; Morzycka-Michalik M; Paczek L; Modlinska M; Gorski A
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1002. PubMed ID: 2650060
    [No Abstract]   [Full Text] [Related]  

  • 34. Transplant glomerulopathy contribution to the decline of renal function in chronic rejection of renal transplants.
    Savin M; Blagojevic R; Djukanovic L; Sindjic M; Radivojevic D; Hadzidjokic J
    Transplant Proc; 1995 Feb; 27(1):922-4. PubMed ID: 7879231
    [No Abstract]   [Full Text] [Related]  

  • 35. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
    Billen EV; Christiaans MH; van den Berg-Loonen EM
    Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cadaveric kidney transplantation in patients with lymphocytotoxic autoantibodies.
    Emonds MP; Dendievel J; Roels L; Waer M; Vanrenterghem Y; Vermylen C
    Transplant Proc; 1992 Dec; 24(6):2502-3. PubMed ID: 1465845
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of HLA Matchmaker compatibility as predictor of graft survival and presence of Anti-HLA antibodies.
    Silva E; Alba A; Castro A; Carrascal M; Buckel E; Aguiló J; Herzog C; Calabrán L; Morales J; Fierro JA
    Transplant Proc; 2010; 42(1):266-9. PubMed ID: 20172326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kidney graft recipients with pretransplantation HLA CLASS I antibodies and high soluble CD30 are at high risk for graft loss.
    Rodríguez LM; París SC; Arbeláez M; Cotes JM; Süsal C; Torres Y; García LF
    Hum Immunol; 2007 Aug; 68(8):652-60. PubMed ID: 17678719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of irreversible rejection in the presence of warm anti-donor-HLA class I cytotoxic IgG antibody.
    Shoker A; Klassen J; Herbut B
    Clin Nephrol; 1997 Feb; 47(2):87-91. PubMed ID: 9049455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.